Abstract
The role of individual fatty acids in blood pressure regulation is unclear, although it is known that the modifications in the levels of fatty acids in the diet are able to change the entire profile of fatty acids as well as cholesterol levels in cellular membranes. These chemical changes are accompanied by changes in the physiological state of the cellular membranes and have suggested an influence on cellular metabolism and of course, on the regulatory processes. Local and circulating renin-angiotensin-systems (RAS) are examples of systems that may be involved in the pathogenesis of hypertension. Angiotensin II (AngII) has been considered as the main effector peptide of the RAS, but other peptides derived from the metabolism of AngII, as angiotensin III (AngIII) and angiotensin IV (AngIV) have shown to play significant roles. This review will briefly summarize what is known about the effects of fatty acids, cholesterol and other related compounds on the activity of the aminopeptidases involved in the metabolism of Ang II and AngIII. We conclude that these enzyme activities may be modified in different way, and therefore, possible modifications in RAS and in cardiovascular illness may be possible too.
Keywords: Renin-angiotensin system, hypertension, aminopeptidase A, aminopeptidase B, aminopeptidase N, fatty acids, cholesterol, dietary manipulation
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Dietary Fat and Hypertension: A Novel Approach Through the Proteolytic Regulatory Enzymes of the Renin-Angiotensin-System
Volume: 4 Issue: 3
Author(s): J. M. Martinez-Martos and M. J. Ramirez-Exposito
Affiliation:
Keywords: Renin-angiotensin system, hypertension, aminopeptidase A, aminopeptidase B, aminopeptidase N, fatty acids, cholesterol, dietary manipulation
Abstract: The role of individual fatty acids in blood pressure regulation is unclear, although it is known that the modifications in the levels of fatty acids in the diet are able to change the entire profile of fatty acids as well as cholesterol levels in cellular membranes. These chemical changes are accompanied by changes in the physiological state of the cellular membranes and have suggested an influence on cellular metabolism and of course, on the regulatory processes. Local and circulating renin-angiotensin-systems (RAS) are examples of systems that may be involved in the pathogenesis of hypertension. Angiotensin II (AngII) has been considered as the main effector peptide of the RAS, but other peptides derived from the metabolism of AngII, as angiotensin III (AngIII) and angiotensin IV (AngIV) have shown to play significant roles. This review will briefly summarize what is known about the effects of fatty acids, cholesterol and other related compounds on the activity of the aminopeptidases involved in the metabolism of Ang II and AngIII. We conclude that these enzyme activities may be modified in different way, and therefore, possible modifications in RAS and in cardiovascular illness may be possible too.
Export Options
About this article
Cite this article as:
Martinez-Martos M. J. and Ramirez-Exposito J. M., Dietary Fat and Hypertension: A Novel Approach Through the Proteolytic Regulatory Enzymes of the Renin-Angiotensin-System, Cardiovascular & Hematological Agents in Medicinal Chemistry 2006; 4 (3) . https://dx.doi.org/10.2174/187152506777698308
DOI https://dx.doi.org/10.2174/187152506777698308 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Altered Steroid Metabolism and Insulin Signaling in PCOS Endometria: Impact in Tissue Function
Current Pharmaceutical Design Hydrogen Gas as an Exotic Performance-Enhancing Agent: Challenges and Opportunities
Current Pharmaceutical Design Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future
Current Pharmaceutical Design Association of Neutrophil-Lymphocyte Ratio with Mild Cognitive Impairment in Elderly Chinese Adults: A Case-control Study
Current Alzheimer Research Garlic for Cardiovascular Disease: Prevention or Treatment?
Current Pharmaceutical Design Angiotensin II in Type 2 Diabetes Mellitus
Current Protein & Peptide Science Analysis of Process and Formulation Variables on Chitosan based Losartan Potassium Nanoparticles: Preparation, Validation and in vitro Release Kinetics
Recent Innovations in Chemical Engineering Amaranth: A Pseudo-Cereal with Nutraceutical Properties
Current Nutrition & Food Science Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Editorial [Hot topic: In Silico Approaches in G Protein-Coupled Receptors (GPCRs) Drug Discovery: Quo Vadis? (Executive Editor: Stefano Moro)]
Current Pharmaceutical Design QT Prolongation and Anticancer Drugs: Is it a Cardiologist’s Worry? The Oncologist’s Point of View
Reviews on Recent Clinical Trials A Novel Therapeutic Strategy Against Vascular Disorders with Chymase Inhibitor
Current Vascular Pharmacology The Molecular and Cellular Basis of Atherosclerosis and Plaque Rupture
Current Cardiology Reviews A Hybrid PSO-DEFS Based Feature Selection for the Identification of Diabetic Retinopathy
Current Diabetes Reviews Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication
Current Pharmaceutical Design Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases
Current Topics in Medicinal Chemistry